"As a doctor, it is my duty to evaluate the situation with as much data as I can gather and as much expertise as I have and as much experience as I have to determine whether or not the wish of the patient is medically justified" This quote would be so great and remarquable today in the time of big data and digital health revolution if it would not have be written by Dr Jack Kevorkian, better known as "Dr. But in my opinion he was more than right regarding the data he would be able to gather alongside his expertise and experience but it should have be used to cure and save lives, not to do euthanasia. Today too many people and quite often doctors themselves are feeding a competition or even a fight between Big Data and especially Artificial Intelligence and Healthcare Practitioners. What should end up into a major and seamless collaboration between today's fast moving health technologies including AI in particular and doctors, is unfortunately starting with such unnecessary egocentric time consuming and time wasting discussions and fights. In Beijing on 30th of June 2018, an artificial intelligence (AI) system scored 2:0 against elite human physicians in two rounds of competitions in diagnosing brain tumors and predicting hematoma expansion in Beijing. The BioMind AI system, developed by the Artificial Intelligence Research Centre for Neurological Disorders at the Beijing Tiantan Hospital and a research team from the Capital Medical University, made correct diagnoses in 87 percent of 225 cases in about 15 minutes, while a team of 15 senior doctors only achieved 66-percent accuracy in 30 minutes. The AI also gave correct predictions in 83 percent of brain hematoma expansion cases in 3 minutes, outperforming the 63-percent accuracy in 20 minutes among a group of physicians from renowned hospitals across the country. The outcomes for human physicians were quite normal and even better than the average accuracy in ordinary hospitals, said Gao Peiyi, head of the radiology department at Tiantan Hospital, a leading institution on neurology and neurosurgery. To train the AI, developers fed it with tens of thousands of images of nervous system-related diseases that the Tiantan Hospital has archived over the past 10 years, making it capable of diagnosing common neurological diseases such as meningioma and glioma with an accuracy rate of over 90 percent, comparable to that of a senior doctor. All the cases were real and contributed by the hospital, but never used as training material for the AI, according to the organizer. Wang Yongjun, executive vice president of the Tiantan Hospital, said that he personally did not care very much about who won, because the contest was never intended to pit humans against technology but to help doctors learn and improve through interactions with technology. "I hope through this competition, doctors can experience the power of artificial intelligence.

It was not the football World Cup, but the defeat was not unlike Christiano Ronaldo and Lionel Messi losing on the same day. An artificial intelligence system recorded a 2-0 victory against elite physicians on 30 June 2018 in two rounds of a competition in Beijing to diagnose brain tumours and predict the expansion of brain hematomas, or bruises. BioMind, developed by researchers from the AI Research Centre for Neurological Disorders and Capital Medical University, made correct diagnoses in 87 per cent of 225 cases in about 15 minutes. A team of 15 doctors from top hospitals across China achieved 66 per cent accuracy in 30 minutes. The AI system also made correct predictions in 83 per cent of brain hematoma expansion cases, outperforming the physicians, who had only 63 per cent accuracy.

It was not the football World Cup, but the defeat was not unlike Christiano Ronaldo and Lionel Messi losing on the same day. An artificial intelligence system recorded a 2-0 victory against elite physicians on 30 June 2018 in two rounds of a competition in Beijing to diagnose brain tumours and predict the expansion of brain hematomas, or bruises. BioMind, developed by researchers from the AI Research Centre for Neurological Disorders and Capital Medical University, made correct diagnoses in 87 per cent of 225 cases in about 15 minutes. A team of 15 doctors from top hospitals across China achieved 66 per cent accuracy in 30 minutes. The AI system also made correct predictions in 83 per cent of brain hematoma expansion cases, outperforming the physicians, who had only 63 per cent accuracy.

A Chinese AI system diagnosed brain tumors and other conditions more accurately and faster than a team of top Chinese physicians, according to Xinhua. The AI, called BioMind, was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Beijing Tiantan Hospital. The AI correctly diagnosed 87 percent of 225 cases in just 15 minutes, while a team of 15 senior physicians diagnosed 66-percent of the cases accurately. When it came to predicting cases of brain hematoma expansion, the AI won yet again: with correction predictions in 83 percent of cases, whereas doctors only achieved 63-percent. And that's not because the doctors were slacking.

A custom-built AI designed to diagnose brain tumors and predict hematoma expansion dominated some of China's best doctors in a competition last Saturday in Beijing. The AI, dubbed BioMind, ultimately scored 2:0 against its human competitors, comprised of 15 senior doctors from China's premier hospitals. BioMind was developed by a collaboration between a team from the Artificial Intelligence Research Center for Neurological Disorders at the Beijing Tiantan Hospital and researchers from the Capital Medical University. BioMind's developers opted to feed the AI with data sets featuring tens of thousands of images depicting nervous-system-related diseases, which were retrieved from Tiantan Hospital's archives stretching over the past decade. Wang Yongjun, executive vice-president of Tiantan Hospital, stated that this training ultimately enabled the AI to become proficient in diagnosing neurological diseases such as meningioma and glioma with an accuracy rate of over 90%.

An AI has defeated China's top doctors when competing on detection of a brain tumors and predicting the hematoma expansion. The system defeated a team of doctors who were top 15 in the nation. The AI is named BioMind and it was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Tiantan Hospital in Beijing. BioMind was correct 87% of the time while the doctors have reached 66% accuracy. While the AI took just 15 minutes to find 225 cases the doctors took double the time.

HOW many times have we heard of doctors misdiagnosing patient? It's why most people prefer to get a second and maybe even a third opinion about serious medical conditions. However, with advancements in artificial intelligence (AI), can you imagine how amazing it would be if we could build and train algorithms that look for all the right markers, consider several hundred factors, and take into account all the possible permutations and combinations to deliver "perfect" or even "near perfect" results? Well, news from China suggests that the technology just came to life. According to The Star, an AI-powered system, dubbed BioMind by its creators at the AI Research Centre for Neurological Disorders and Capital Medical University, has defeated elite physicians in two rounds of a medical competition in Beijing.